Diflunisal Impurity 8 | CAS 323-87-5 - Request Quote
Diflunisal Impurity 8
| SZ CAT No: | SZ-D104012 |
| CAS No | 323-87-5 |
| Mol.F. | C13H10O3 |
| Mol.Wt. | 214.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Diflunisal Impurity 8 is chemically 4-Hydroxy-3-Biphenyl Carboxylic Acid. Diflunisal Impurity 8 is supplied with detailed characterization data compliant with regulatory guideline. Diflunisal Impurity 8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Diflunisal.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 323-87-5
Purchase 323-87-5
Order 323-87-5
Enquire 323-87-5
price of 323-87-5
323-87-5 Supplier
323-87-5 Manufacturer
323-87-5 Exporter
buy high quality Diflunisal Impurity 8
Purchase Diflunisal Impurity 8
Diflunisal Impurity 8 suppliers
Diflunisal Impurity 8 manufacturers
Diflunisal Impurity 8 price
Order Diflunisal Impurity 8
Enquire Diflunisal Impurity 8
Diflunisal Impurity 8 cost
Diflunisal Impurity 8 Supplier
Diflunisal Impurity 8 Distributor
Diflunisal Impurity 8 for Method Validation
Diflunisal Reference Standard
Diflunisal Impurity 8 for ANDA Filing
Diflunisal Impurity 8 for Forced Degradation Studies
Diflunisal Impurity 8 Identification Standards
Diflunisal Impurity 8 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


